Cargando…
Reply to: Cause or consequence?
SABINA III shows associations between SABA prescriptions and poor asthma outcomes and does not imply causation. However, implying that high SABA use is simply a “consequence” of poor asthma control is also an oversimplification of a complex issue. https://bit.ly/3rXKSGm
Autores principales: | Bateman, Eric D., Price, David B., Wang, Hao-Chien, Schonffeldt, Patricia, Catanzariti, Angelina, van der Valk, Ralf J.P., Beekman, Maarten J.H.I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178210/ https://www.ncbi.nlm.nih.gov/pubmed/35210324 http://dx.doi.org/10.1183/13993003.00103-2022 |
Ejemplares similares
-
Short-acting β(2)-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study
por: Bateman, Eric D., et al.
Publicado: (2022) -
Reply to: “Current smoking is not associated with COVID-19”
por: Leung, Janice M., et al.
Publicado: (2020) -
Reply: Is high-dose glucocorticoid beneficial in COVID-19?
por: Edalatifard, Maryam, et al.
Publicado: (2021) -
Reply to comment on “The natural history of progressive fibrosing interstitial lung diseases”
por: Brown, Kevin K., et al.
Publicado: (2020) -
Reply to “COVID-19 prediction models should adhere to methodological and reporting standards”
por: Wu, Guangyao, et al.
Publicado: (2020)